
Kristina Danielsson-Gemzell
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Expulsion rates and risk factors for intrauterine device expulsion following medical management of first-trimester incomplete abortions: A prospective cohort study in central Uganda.
Journal: BMJ sexual & reproductive health
Published: September 05, 2025
The clinical relevance of having more than one estrogen in combined hormonal contraception to address the needs of women.
Journal: Best practice & research. Clinical obstetrics & gynaecology
Published: June 29, 2024
Home use of mifepristone for medical abortion: a systematic review.
Journal: BMJ sexual & reproductive health
Published: March 04, 2024
Levonorgestrel intrauterine device and depression: A Swedish register-based cohort study.
Journal: International journal of psychophysiology : official journal of the International Organization of Psychophysiology
Published: February 17, 2023
Corrigendum to "Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system".
Journal: Contraception
Published: November 18, 2022
Persistent organic pollutants and the size of ovarian reserve in reproductive-aged women.
Journal: Environment international
Published: February 07, 2021
Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: December 09, 2019
Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation.
Journal: Contraception
Published: September 27, 2018
Estimating abortion safety: advancements and challenges.
Journal: Lancet (London, England)
Published: June 22, 2017
Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter® in a majority nulliparous population.
Journal: Contraception
Published: December 01, 2016
Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids.
Journal: Contemporary clinical trials
Published: September 05, 2016
Last Updated: 09/26/2026